Kintor Pharmaceutical Ltd (HK:9939) has released an update.
Kintor Pharmaceutical Ltd has announced its Annual General Meeting to be held on June 20, 2024, in Suzhou Industrial Park, where shareholders will review the company’s audited financial statements, re-elect directors, and re-appoint its auditor, PricewaterhouseCoopers. Additionally, the meeting will consider authorizing the Board to issue and deal with additional shares and securities. These actions are standard procedure to ensure the company maintains transparency and shareholder engagement.
For further insights into HK:9939 stock, check out TipRanks’ Stock Analysis page.